Association of eptifibatide and acute profound thrombocytopenia

This publication has 18 references indexed in Scilit:

• Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
  The Lancet, 2000
• Clinical Significance of Thrombocytopenia During a Non–ST-Elevation Acute Coronary Syndrome
  Circulation, 1999
• Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization
  Journal of the American College of Cardiology, 1998
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
  The Lancet, 1998
• Thrombocytopenia With GP IIb/IIIa Inhibitors: A Meta-Analysis
  Journal of the American College of Cardiology, 1998
• Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
  New England Journal of Medicine, 1997
• Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
  The Lancet, 1997
• Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
  The Lancet, 1997
• Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy
  Circulation, 1997
• Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion
  The American Journal of Cardiology, 1996